HSE bucks global trend and reverses fall in cervical cancer vaccine uptake
The latest vaccine figures will come as a relief to doctors and other healthcare professionals who had expressed serious concern about successive drops in recent years
The HSE has reversed the decline in uptake of the cervical cancer vaccine, making Ireland the first country to successfully fight back against campaigners who eroded public confidence in the vaccine.
Provisional figures show uptake of the vaccine increased to 61 per cent this year - up from 50 per cent last year.
The rise is regarded as significant as it has taken public health authorities years to recover from previous scares such as wholly discredited claims...
Subscribe from just €1 for the first month!
With any subscription you will have access to
Unlimited multi-device access to our iPad, iPhone and Android Apps
Unlimited access to our eReader library
Exclusive daily insight and opinion seven days a week
Create alerts to never miss a subject that matters to you
Get access to exclusive offers for subscribers on gifts and experiences
Get content from Business Post, Business Post Magazines, Connected, Tatler and Food & Wine
Editorial: Our inability to agree on a model of healthcare in Ireland is unacceptable
The government is failing in its duties to provide a working healthcare system
HSE yet to cooperate with Sláintecare business case
There are concerns that the deadline for the business case, which concerns regionalisation plans, will be missed unless the HSE agrees to take part
Healthcare software developers claim they could cut waiting lists by 25%
The Irish Hospital Consultants Association has warned that the numbers waiting for either treatment or a consultation will soon increase to over one million patients
Tony O’Brien: The apparent slow collapse of Sláintecare deserves more than a shrug of the shoulders
Downplaying and media management dominated the government’s response to the resignation of Laura Magahy and Tom Keane from the Sláintecare programme